Advances in Chemotheraphy - 1st Edition - ISBN: 9781483199290, 9781483224329

Advances in Chemotheraphy

1st Edition

Volume 1

Editors: Abraham Goldin F. Hawking
eBook ISBN: 9781483224329
Imprint: Academic Press
Published Date: 1st January 1964
Page Count: 592
Sales tax will be calculated at check-out Price includes VAT/GST
20% off
20% off
30% off
20% off
20% off
30% off
20% off
20% off
30% off
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Advances in Chemotherapy, Volume 1 presents the significant progress both in theoretical and experimental aspects in the various disciplines comprising chemotherapy field.
This volume is divided into nine chapters, and begins with an introduction to the historical developments in chemotherapy. The subsequent chapters deal with the nature, use, and limitations of drug predictive systems and the experimental results concerning the trypanocidal activity of phenanthridine and aminoquinaldine. These topics are followed by discussions on chemoprophylaxis and chemotherapy of tumor viruses, the antitumor activity of alkaloidal substances from Vinca rosea plant, and the correlation between inhibitory activity in mammalian cell assays and experimental antitumor activity. A chapter considers the interplay of immune mechanisms and drugs in the clinical and veterinary aspects of antiparasitic chemotherapy. The final chapters look into some of the pharmacological, therapeutic, and biochemical bases for the combined actions of drugs, with special emphasis on the combination chemotherapy of cancer and factors which may influence its effectiveness. These chapters also describe the concept of using inhibitors in chemotherapy. This book will prove useful to oncologists and other workers in the medical profession with background of chemotherapy.

Table of Contents

List of Contributors


Historical Perspectives in Chemotherapy

Quantitative Concepts in the Clinical Study of Drugs

I. Introduction

II. Preclinical Studies

III. Clinical Considerations

IV. Summary


Mechanisms of Action of Phenanthridine and Aminoquinaldine Trypanocides

I. Introduction

II. Trypanosomiasis in Africa: Present-Day Aspects

III. Problems Peculiar to Studies of the Mode of Action of Trypanocides: Blood-Stream and Culture Forms of Trypanosomes

IV. Use of an Insect Flagellate as a Test System for Studies on Drug Action: Advantages and Limitations

V. Drugs in Use for Treatment of Trypanosomiasis in Cattle

VI. Characteristics of the Trypanocidal Action of Phenanthridines and Aminoquinaldines: In Vivo Studies

VII. In Vitro Studies Using Crithidia oncopelti as Test Organism

VIII. Effects of Phenanthridines on Other Cell Systems

IX. Drug Resistance to Phenanthridines and Aminoquinaldines

X. Mechanisms of Action and the Problem of Selective Toxicity: Conclusions and Speculations


Chemoprophylaxis and Chemotherapy of Viral Diseases

I. Introduction

II. Factors Influencing Recovery from Viral Diseases

III. Materials with Chemoprophylactic or Chemotherapeutic Activity

IV. Tumor Viruses

V. Comment


The Vinca Alkaloids

1. General Introduction

II. Preparation, Chemistry, and Structural Relationships

III. Experimental Biological Properties

IV. Clinical Experiences

V. Summary


Cell Culture and Cancer Chemotherapy

I. Introduction

II. Methods

III. Cell Lines

IV. Nutritional and Biochemical Studies

V. Growth-Regulatory Factors

VI. Maintenance and Loss of Specific Functional Capacities

VII. Mammalian Cell Cultures as an Assay for Potential Antitumor Activity

VIII. Organ Culture

IX. Comment


Immunoreactions in Antiparasitic Chemotherapy

I. Introduction

II. Components of the Drug-Host-Parasite Complex

III. Immunoreactions in Experimental Antiparasitic Chemotherapy

IV. Immunoreactions in Antiparasitic Chemotherapy in the Clinic and in the Field


Drug Synergism in Antineoplastic Chemotherapy

I. The Concept of Therapeutic Synergism

II. Parameters of Response to Therapy of Neoplastic Disease

III. The Pharmacological and Therapeutic Bases for Synergism

IV. The Biochemical Basis for Antitumor Synergism

V. Combination Chemotherapy of Cancer Patients

VI. Conclusions


New Concepts of the Use of Inhibitors in Chemotherapy

I. The Classical Antimetabolite Approach

II. New Inhibitors Based on Allosteric Inhibition

III. Enzyme Subunits and Allosteric Phenomena

IV. Multiple Forms of Enzymes

V. Sulfanilamide Inhibition and Folic Acid Synthesis

VI. Virus-Induced Enzymes

VII. Lethal Synthesis and Feedback Inhibition

VIII. DPN Analogs

IX. Homofolate

X. New Inhibitors that Interfere with or Redirect Information Transfer

XI. Mechanism of Actinomycin Inhibition

XII. Hormone Effects

XIII. Specific Inhibition of DNA Replication

XIV. Drugs that Directly Influence Mitotic Processes

XV. Conclusion


Author Index

Subject Index


No. of pages:
© Academic Press 1964
Academic Press
eBook ISBN:

About the Editor

Abraham Goldin

F. Hawking

Affiliations and Expertise

Clinical Research Centre, Harrow, Middlesex, England

Ratings and Reviews